BioAtla (BCAB) Earnings Date, Estimates & Call Transcripts $0.44 +0.01 (+1.71%) As of 05/13/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioAtla Earnings Summary BioAtla posted Q1 2025 earnings on May 6, 2025, reporting an EPS of -$0.29, which missed analysts' consensus estimates of -$0.28 by $0.01. With a trailing EPS of -$1.22, BioAtla's earnings are expected to grow next year, from ($1.46) to ($1.40) per share. Latest Q1 Earnings DateMay. 6EstimatedConsensus EPS (May. 6) -$0.28 Actual EPS (May. 6) -$0.29 Missed By -$0.01 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)Powered by Get BioAtla Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioAtla and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBCAB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. BioAtla Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.28-$0.28-$0.28Q2 20251-$0.29-$0.29-$0.29Q3 20251-$0.29-$0.29-$0.29Q4 20251-$0.33-$0.33-$0.33 FY 2025 4 -$1.19 -$1.19 -$1.19 Q1 20261-$0.35-$0.35-$0.35Q2 20261-$0.36-$0.36-$0.36Q3 20261-$0.38-$0.38-$0.38Q4 20261-$0.39-$0.39-$0.39 BioAtla Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025-$0.28-$0.29 -$0.01-$0.26--3/27/2025Q4 2024-$0.40-$0.32+$0.08-$0.34--11/7/2024Q3 2024-$0.34-$0.22+$0.12-$0.22-$11.00M8/8/2024Q2 2024-$0.45-$0.44+$0.01-$0.44--5/14/2024Q1 2024-$0.57-$0.48+$0.09-$0.48--3/26/2024Q4 2023-$0.68-$0.56+$0.12-$0.56--11/7/2023Q3 2023-$0.77-$0.70+$0.07-$0.70--8/1/2023Q2 2023-$0.62-$0.75 -$0.13-$0.75-- BioAtla Earnings - Frequently Asked Questions When did BioAtla announce their last quarterly earnings? BioAtla (NASDAQ:BCAB) last announced its quarterly earning data on Tuesday, May 6, 2025. Learn more on BCAB's earnings history. Did BioAtla beat their earnings estimates last quarter? In the previous quarter, BioAtla (NASDAQ:BCAB) missed the analysts' consensus estimate of ($0.28) by $0.01 with a reported earnings per share (EPS) of ($0.29). Learn more on analysts' earnings estimate vs. BCAB's actual earnings. How can I listen to BioAtla's earnings conference call? The conference call for BioAtla's latest earnings report can be listened to online. Listen to Conference Call How can I read BioAtla's conference call transcript? The conference call transcript for BioAtla's latest earnings report can be read online. Read Transcript How much revenue does BioAtla generate each year? BioAtla (NASDAQ:BCAB) has a recorded annual revenue of $11 million. How much profit does BioAtla generate each year? BioAtla (NASDAQ:BCAB) has a recorded net income of -$123.46 million. BCAB has generated -$1.22 earnings per share over the last four quarters. What is BioAtla's EPS forecast for next year? BioAtla's earnings are expected to grow from ($1.46) per share to ($1.40) per share in the next year. More Earnings Resources from MarketBeat Related Companies RAPT Therapeutics Earnings Date Coherus BioSciences Earnings Date Silence Therapeutics Earnings Date Enanta Pharmaceuticals Earnings Date Alector Earnings Date C4 Therapeutics Earnings Date Atossa Therapeutics Earnings Date Neumora Therapeutics Earnings Date InflaRx Earnings Date Sagimet Biosciences Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? This page (NASDAQ:BCAB) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersThe world’s first multi- trillion-dollar robotics industry …Robots are standing on the edge of history. No one would know this better than Nvidia's Jensen Huang. In...Weiss Ratings | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s third-term comments grabbed headlines, but the bigger story is what he’s planning next. A new report ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAtla, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioAtla With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
